Evolution Wealth Advisors, LLC
- SEC CIK
- 0001763121
- Latest filing
- Jul 29, 2026
Holdings changes from Q2 2021 to Q3 2021
Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.
- New
- 69
- Est. +$8.55M
- Added
- 145
- Est. +$40.5M
- Reduced
- 139
- Est. −$49.2M
- Sold out
- 32
- Est. −$12.2M
Portfolio value went from $492.1M to $466.6M (−$25.5M (−5.2%)); positions from 626 to 663 (+37).
All Q3 2021 holdingsAll Q2 2021 holdings
In the shares, value and % of portfolio columns, the top figure is Q3 2021 and the gray one below is Q2 2021. For stocks that split between the two quarters, Q2 2021 shares are converted at the split ratio before comparing.
| Security | Action | Shares | Share change | Value | Est. bought or sold | % of portfolio | Weight change (pp) |
|---|---|---|---|---|---|---|---|
| CLXClorox Co | ReducedHistory | 14164 | −150−91.5% | $2.00K$30.0K | −$21.4K | <0.1%<0.1% | −0.01 |
| EPIXESSA Pharma Inc. | ReducedHistory | 287292 | −5−1.7% | $2.00K$8.00K | −$34.84 | <0.1%<0.1% | 0.00 |
| RCKTRocket Pharmaceuticals, Inc. | ReducedHistory | 60153 | −93−60.8% | $2.00K$7.00K | −$3.10K | <0.1%<0.1% | 0.00 |
| NTLAIntellia Therapeutics, Inc. | ReducedHistory | 1730 | −13−43.3% | $2.00K$5.00K | −$1.53K | <0.1%<0.1% | 0.00 |
| TSNTyson Foods, Inc. | ReducedHistory | 3525,596 | −25,561−99.9% | $3.00K$1.89M | −$2.19M | <0.1%0.4% | −0.38 |
| BBIOBridgeBio Pharma, Inc. | ReducedHistory | 68203 | −135−66.5% | $3.00K$12.0K | −$5.96K | <0.1%<0.1% | 0.00 |
| RYTMRhythm Pharmaceuticals, Inc. | ReducedHistory | 213538 | −325−60.4% | $3.00K$11.0K | −$4.58K | <0.1%<0.1% | 0.00 |
| ACCDAccolade, Inc. | ReducedHistory | 82205 | −123−60.0% | $3.00K$11.0K | −$4.50K | <0.1%<0.1% | 0.00 |
| FATEFate Therapeutics Inc | ReducedHistory | 48120 | −72−60.0% | $3.00K$10.0K | −$4.50K | <0.1%<0.1% | 0.00 |
| ACADAcadia Pharmaceuticals Inc | ReducedHistory | 162362 | −200−55.2% | $3.00K$9.00K | −$3.70K | <0.1%<0.1% | 0.00 |
| OLMAOlema Pharmaceuticals, Inc. | ReducedHistory | 126316 | −190−60.1% | $3.00K$9.00K | −$4.52K | <0.1%<0.1% | 0.00 |
| BCABBioAtla, Inc. | ReducedHistory | 110217 | −107−49.3% | $3.00K$9.00K | −$2.92K | <0.1%<0.1% | 0.00 |
| SAGESage Therapeutics, Inc. | ReducedHistory | 60151 | −91−60.3% | $3.00K$9.00K | −$4.55K | <0.1%<0.1% | 0.00 |
| SHCSotera Health Co | ReducedHistory | 114320 | −206−64.4% | $3.00K$8.00K | −$5.42K | <0.1%<0.1% | 0.00 |
| KODKodiak Sciences Inc. | ReducedHistory | 3075 | −45−60.0% | $3.00K$7.00K | −$4.50K | <0.1%<0.1% | 0.00 |
| ALGSAligos Therapeutics, Inc. | ReducedHistory | 194317 | −123−38.8% | $3.00K$6.00K | −$1.90K | <0.1%<0.1% | 0.00 |
| CRDFCardiff Oncology, Inc. | ReducedHistory | 429810 | −381−47.0% | $3.00K$5.00K | −$2.66K | <0.1%<0.1% | 0.00 |
| COLLCollegium Pharmaceutical, Inc | ReducedHistory | 211532 | −321−60.3% | $4.00K$13.0K | −$6.09K | <0.1%<0.1% | 0.00 |
| GBTGlobal Blood Therapeutics, Inc. | ReducedHistory | 145366 | −221−60.4% | $4.00K$13.0K | −$6.10K | <0.1%<0.1% | 0.00 |
| PTCTPTC Therapeutics, Inc. | ReducedHistory | 116291 | −175−60.1% | $4.00K$12.0K | −$6.03K | <0.1%<0.1% | 0.00 |
| MRTXMirati Therapeutics, Inc. | ReducedHistory | 2470 | −46−65.7% | $4.00K$11.0K | −$7.67K | <0.1%<0.1% | 0.00 |
| ALXOAlx Oncology Holdings Inc | ReducedHistory | 60178 | −118−66.3% | $4.00K$10.0K | −$7.87K | <0.1%<0.1% | 0.00 |
| PHATPhathom Pharmaceuticals, Inc. | ReducedHistory | 114288 | −174−60.4% | $4.00K$10.0K | −$6.11K | <0.1%<0.1% | 0.00 |
| FDMT4D Molecular Therapeutics, Inc. | ReducedHistory | 145361 | −216−59.8% | $4.00K$9.00K | −$5.96K | <0.1%<0.1% | 0.00 |
| SILKSilk Road Medical Inc | ReducedHistory | 73185 | −112−60.5% | $4.00K$9.00K | −$6.14K | <0.1%<0.1% | 0.00 |
| HRMYHarmony Biosciences Holdings, Inc. | ReducedHistory | 107292 | −185−63.4% | $4.00K$8.00K | −$6.92K | <0.1%<0.1% | 0.00 |
| TAKTakeda Pharmaceutical Co Ltd | ReducedHistory | 277852 | −575−67.5% | $5.00K$14.0K | −$10.4K | <0.1%<0.1% | 0.00 |
| DGXQuest Diagnostics Inc | ReducedHistory | 34101 | −67−66.3% | $5.00K$13.0K | −$9.85K | <0.1%<0.1% | 0.00 |
| HCATHealth Catalyst, Inc. | ReducedHistory | 96241 | −145−60.2% | $5.00K$13.0K | −$7.55K | <0.1%<0.1% | 0.00 |
| AKROAkero Therapeutics, Inc. | ReducedHistory | 211533 | −322−60.4% | $5.00K$13.0K | −$7.63K | <0.1%<0.1% | 0.00 |
| NEONeogenomics Inc | ReducedHistory | 104264 | −160−60.6% | $5.00K$12.0K | −$7.69K | <0.1%<0.1% | 0.00 |
| ICUIIcu Medical Inc | ReducedHistory | 2056 | −36−64.3% | $5.00K$12.0K | −$9.00K | <0.1%<0.1% | 0.00 |
| BCYCBicycle Therapeutics PLC | ReducedHistory | 120397 | −277−69.8% | $5.00K$12.0K | −$11.5K | <0.1%<0.1% | 0.00 |
| PRAXPraxis Precision Medicines, Inc. | ReducedHistory | 257642 | −385−60.0% | $5.00K$12.0K | −$7.49K | <0.1%<0.1% | 0.00 |
| FOLDAmicus Therapeutics, Inc. | ReducedHistory | 482857 | −375−43.8% | $5.00K$8.00K | −$3.89K | <0.1%<0.1% | 0.00 |
| TVTXTravere Therapeutics, Inc. | ReducedHistory | 212451 | −239−53.0% | $5.00K$7.00K | −$5.64K | <0.1%<0.1% | 0.00 |
| BAXBaxter International Inc | ReducedHistory | 74214 | −140−65.4% | $6.00K$17.0K | −$11.4K | <0.1%<0.1% | 0.00 |
| MYOVMyovant Sciences Ltd. | ReducedHistory | 288727 | −439−60.4% | $6.00K$17.0K | −$9.15K | <0.1%<0.1% | 0.00 |
| RPRXRoyalty Pharma plc | ReducedHistory | 154386 | −232−60.1% | $6.00K$16.0K | −$9.04K | <0.1%<0.1% | 0.00 |
| TNDMTandem Diabetes Care Inc | ReducedHistory | 52130 | −78−60.0% | $6.00K$13.0K | −$9.00K | <0.1%<0.1% | 0.00 |
| ALLKAllakos Inc. | ReducedHistory | 59126 | −67−53.2% | $6.00K$11.0K | −$6.81K | <0.1%<0.1% | 0.00 |
| JAZZJazz Pharmaceuticals plc | ReducedHistory | 56132 | −76−57.6% | $7.00K$23.0K | −$9.50K | <0.1%<0.1% | 0.00 |
| GMEDGlobus Medical Inc | ReducedHistory | 94266 | −172−64.7% | $7.00K$21.0K | −$12.8K | <0.1%<0.1% | 0.00 |
| XRAYDentsply Sirona Inc. | ReducedHistory | 145394 | −249−63.2% | $8.00K$25.0K | −$13.7K | <0.1%<0.1% | 0.00 |
| ELANElanco Animal Health Inc | ReducedHistory | 258652 | −394−60.4% | $8.00K$23.0K | −$12.2K | <0.1%<0.1% | 0.00 |
| STESTERIS plc | ReducedHistory | 3896 | −58−60.4% | $8.00K$20.0K | −$12.2K | <0.1%<0.1% | 0.00 |
| CTLTCatalent, Inc. | ReducedHistory | 62170 | −108−63.5% | $8.00K$18.0K | −$13.9K | <0.1%<0.1% | 0.00 |
| XLRNAcceleron Pharma Inc | ReducedHistory | 47130 | −83−63.8% | $8.00K$16.0K | −$14.1K | <0.1%<0.1% | 0.00 |
| BHVNBiohaven Ltd. | ReducedHistory | 56152 | −96−63.2% | $8.00K$15.0K | −$13.7K | <0.1%<0.1% | 0.00 |
| BKRBaker Hughes Co | ReducedHistory | 315480 | −165−34.4% | $8.00K$11.0K | −$4.19K | <0.1%<0.1% | 0.00 |
| DALDelta Air Lines, Inc. | ReducedHistory | 20024,827 | −24,627−99.2% | $9.00K$1.07M | −$1.11M | <0.1%0.2% | −0.22 |
| BMRNBiomarin Pharmaceutical Inc | ReducedHistory | 116293 | −177−60.4% | $9.00K$24.0K | −$13.7K | <0.1%<0.1% | 0.00 |
| ARGXArgenx SE | ReducedHistory | 3075 | −45−60.0% | $9.00K$23.0K | −$13.5K | <0.1%<0.1% | 0.00 |
| INSMINSMED Inc | ReducedHistory | 367918 | −551−60.0% | $10.0K$26.0K | −$15.0K | <0.1%<0.1% | 0.00 |
| REGNRegeneron Pharmaceuticals, Inc. | ReducedHistory | 1644 | −28−63.6% | $10.0K$25.0K | −$17.5K | <0.1%<0.1% | 0.00 |
| TFXTeleflex Inc | ReducedHistory | 29109 | −80−73.4% | $11.0K$44.0K | −$30.3K | <0.1%<0.1% | −0.01 |
| COOCooper Companies, Inc. | ReducedHistory | 3067 | −37−55.2% | $12.0K$27.0K | −$14.8K | <0.1%<0.1% | 0.00 |
| DOCUDocuSign, Inc. | ReducedHistory | 4770 | −23−32.9% | $12.0K$20.0K | −$5.87K | <0.1%<0.1% | 0.00 |
| RCLRoyal Caribbean Cruises Ltd | ReducedHistory | 15113,100 | −12,949−98.8% | $13.0K$1.12M | −$1.11M | <0.1%0.2% | −0.22 |
| BABoeing Co | ReducedHistory | 601,560 | −1,500−96.2% | $13.0K$374.0K | −$325.0K | <0.1%0.1% | −0.07 |
| ILMNIllumina, Inc. | ReducedHistory | 3179 | −48−60.8% | $13.0K$37.0K | −$20.1K | <0.1%<0.1% | 0.00 |
| IQVIQVIA Holdings Inc. | ReducedHistory | 54141 | −87−61.7% | $13.0K$34.0K | −$20.9K | <0.1%<0.1% | 0.00 |
| GILDGilead Sciences, Inc. | ReducedHistory | 184396 | −212−53.5% | $13.0K$27.0K | −$15.0K | <0.1%<0.1% | 0.00 |
| ASNDAscendis Pharma A/S | ReducedHistory | 88211 | −123−58.3% | $14.0K$28.0K | −$19.6K | <0.1%<0.1% | 0.00 |
| BIDUBaidu, Inc. | ReducedHistory | 100104 | −4−3.8% | $15.0K$21.0K | −$600 | <0.1%<0.1% | 0.00 |
| ELVElevance Health, Inc. | ReducedHistory | 4398 | −55−56.1% | $16.0K$37.0K | −$20.5K | <0.1%<0.1% | 0.00 |
| CFGCitizens Financial Group Inc | ReducedHistory | 348349 | −1−0.3% | $16.0K$16.0K | −$45.98 | <0.1%<0.1% | 0.00 |
| CMRCCommerce.com, Inc. | ReducedHistory | 3301,980 | −1,650−83.3% | $17.0K$129.0K | −$85.0K | <0.1%<0.1% | −0.02 |
| SNYSanofi | ReducedHistory | 343928 | −585−63.0% | $17.0K$49.0K | −$29.0K | <0.1%<0.1% | −0.01 |
| NBIXNeurocrine Biosciences Inc | ReducedHistory | 173404 | −231−57.2% | $17.0K$39.0K | −$22.7K | <0.1%<0.1% | 0.00 |
| KSUKansas City Southern | ReducedHistory | 6368 | −5−7.4% | $17.0K$19.0K | −$1.35K | <0.1%<0.1% | 0.00 |
| SRPTSarepta Therapeutics, Inc. | ReducedHistory | 190422 | −232−55.0% | $18.0K$33.0K | −$22.0K | <0.1%<0.1% | 0.00 |
| CMAComerica Inc | ReducedHistory | 222228 | −6−2.6% | $18.0K$16.0K | −$486.49 | <0.1%<0.1% | 0.00 |
| ISRGIntuitive Surgical Inc | ReducedHistory | 2033 | −13−39.4% | $20.0K$30.0K | −$13.0K | <0.1%<0.1% | 0.00 |
| SYKStryker Corp | ReducedHistory | 81182 | −101−55.5% | $21.0K$47.0K | −$26.2K | <0.1%<0.1% | −0.01 |
| SQMChemical & Mining Co of Chile Inc | ReducedHistory | 400500 | −100−20.0% | $21.0K$24.0K | −$5.25K | <0.1%<0.1% | 0.00 |
| BPBP PLC | ReducedHistory | 790139,787 | −138,997−99.4% | $22.0K$3.69M | −$3.87M | <0.1%0.8% | −0.75 |
| VRTXVertex Pharmaceuticals Inc | ReducedHistory | 121282 | −161−57.1% | $22.0K$57.0K | −$29.3K | <0.1%<0.1% | −0.01 |
| BSXBoston Scientific Corp | ReducedHistory | 5271,319 | −792−60.0% | $23.0K$56.0K | −$34.6K | <0.1%<0.1% | −0.01 |
| CNCCentene Corp | ReducedHistory | 400683 | −283−41.4% | $25.0K$50.0K | −$17.7K | <0.1%<0.1% | 0.00 |
| EWEdwards Lifesciences Corp | ReducedHistory | 224452 | −228−50.4% | $25.0K$47.0K | −$25.4K | <0.1%<0.1% | 0.00 |
| ENPHEnphase Energy, Inc. | ReducedHistory | 164169 | −5−3.0% | $25.0K$31.0K | −$762.2 | <0.1%<0.1% | 0.00 |
| GTMZoomInfo Technologies Inc. | ReducedHistory | 4794,240 | −3,761−88.7% | $29.0K$221.0K | −$227.7K | <0.1%<0.1% | −0.04 |
| FXAInvesco CurrencyShares Australian Dollar Trust | ReducedHistory | 41546,030 | −45,615−99.1% | $30.0K$3.43M | −$3.30M | <0.1%0.7% | −0.69 |
| HUMHumana Inc | ReducedHistory | 77151 | −74−49.0% | $30.0K$67.0K | −$28.8K | <0.1%<0.1% | −0.01 |
| FXCInvesco CurrencyShares Canadian Dollar Trust | ReducedHistory | 41545,375 | −44,960−99.1% | $32.0K$3.59M | −$3.47M | <0.1%0.7% | −0.72 |
| TAT&T Inc. | ReducedHistory | 1,29466,170 | −64,876−98.0% | $35.0K$1.90M | −$1.75M | <0.1%0.4% | −0.38 |
| CLColgate Palmolive Co | ReducedHistory | 510597 | −87−14.6% | $39.0K$49.0K | −$6.65K | <0.1%<0.1% | 0.00 |
| BRF SA10552T107 | Reduced– | 8,108105,551 | −97,443−92.3% | $41.0K$577.0K | −$492.7K | <0.1%0.1% | −0.11 |
| AZNAstraZeneca PLC | ReducedHistory | 7181,760 | −1,042−59.2% | $43.0K$105.0K | −$62.4K | <0.1%<0.1% | −0.01 |
| iShares Tips Bond ETF464287176 | Reduced– | 360635 | −275−43.3% | $46.0K$81.0K | −$35.1K | <0.1%<0.1% | −0.01 |
| NVSNovartis AG | ReducedHistory | 561662 | −101−15.3% | $46.0K$60.0K | −$8.28K | <0.1%<0.1% | 0.00 |
| VALEVale S.A. | ReducedHistory | 3,4094,774 | −1,365−28.6% | $48.0K$109.0K | −$19.2K | <0.1%<0.1% | −0.01 |
| MRNAModerna, Inc. | ReducedHistory | 130145 | −15−10.3% | $50.0K$34.0K | −$5.77K | <0.1%<0.1% | 0.00 |
| PYPLPayPal Holdings, Inc. | ReducedHistory | 198319 | −121−37.9% | $52.0K$93.0K | −$31.8K | <0.1%<0.1% | −0.01 |
| DHRDanaher Corp | ReducedHistory | 175286 | −111−38.8% | $53.0K$77.0K | −$33.6K | <0.1%<0.1% | 0.00 |
| DXCMDexcom Inc | ReducedHistory | 98109 | −11−10.1% | $54.0K$47.0K | −$6.06K | <0.1%<0.1% | 0.00 |
| WFCWells Fargo & Company | ReducedHistory | 1,2075,108 | −3,901−76.4% | $56.0K$231.0K | −$181.0K | <0.1%<0.1% | −0.03 |
| ABTAbbott Laboratories | ReducedHistory | 478737 | −259−35.1% | $56.0K$85.0K | −$30.3K | <0.1%<0.1% | −0.01 |
| XOMExxonMobil Holdings Corp | ReducedHistory | 9651,044 | −79−7.6% | $57.0K$66.0K | −$4.67K | <0.1%<0.1% | 0.00 |
Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.